epigenetic longevity drugs
Longevity Science Vs Regulatory Holdouts Hidden Truth Revealed
Longevity Science Vs Regulatory Holdouts Hidden Truth Revealed Surprising 60% of breakthrough longevity drugs haven’t proven long-term safety, making investors cautious - so the short answer is that they are not yet proven safe enough to be considered low-risk. While epigenetic therapies show promise in slowing biological aging, clinical